DCP
DSM Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-142
| Closed | -$87.8K | – | 90 |
|
2024
Q3 | $87.8K | Hold |
142
| – | – | ﹤0.01% | 51 |
|
2024
Q2 | $78.5K | Hold |
142
| – | – | ﹤0.01% | 51 |
|
2024
Q1 | $82.5K | Sell |
142
-135,019
| -100% | -$78.5M | ﹤0.01% | 54 |
|
2023
Q4 | $71.7M | Sell |
135,161
-6,626
| -5% | -$3.52M | 1.1% | 24 |
|
2023
Q3 | $71.8M | Sell |
141,787
-6,719
| -5% | -$3.4M | 1.21% | 25 |
|
2023
Q2 | $77.5M | Buy |
+148,506
| New | +$77.5M | 1.25% | 26 |
|
2020
Q4 | – | Sell |
-14,405
| Closed | -$6.36M | – | 70 |
|
2020
Q3 | $6.36M | Sell |
14,405
-6,023
| -29% | -$2.66M | 0.07% | 32 |
|
2020
Q2 | $7.4M | Sell |
20,428
-105,156
| -84% | -$38.1M | 0.09% | 32 |
|
2020
Q1 | $35.6M | Sell |
125,584
-311,200
| -71% | -$88.3M | 0.54% | 27 |
|
2019
Q4 | $142M | Buy |
436,784
+10,945
| +3% | +$3.56M | 1.88% | 19 |
|
2019
Q3 | $124M | Sell |
425,839
-3,508
| -0.8% | -$1.02M | 1.91% | 19 |
|
2019
Q2 | $126M | Sell |
429,347
-231,524
| -35% | -$68M | 1.84% | 19 |
|
2019
Q1 | $181M | Sell |
660,871
-33,266
| -5% | -$9.11M | 2.67% | 16 |
|
2018
Q4 | $155M | Sell |
694,137
-60,840
| -8% | -$13.6M | 2.68% | 16 |
|
2018
Q3 | $184M | Sell |
754,977
-12,559
| -2% | -$3.07M | 2.74% | 16 |
|
2018
Q2 | $159M | Buy |
767,536
+59,898
| +8% | +$12.4M | 2.42% | 16 |
|
2018
Q1 | $146M | Buy |
707,638
+508,763
| +256% | +$105M | 2.02% | 17 |
|
2017
Q4 | $37.8M | Buy |
+198,875
| New | +$37.8M | 0.53% | 27 |
|